Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

A novel non-invasive therapy based on injectable viscous gel for restoring the natural biomechanics of the spine and relieving patients from pain

Project description

A game-changing solution for back pain

Intervertebral disc degeneration is a condition that affects the soft, cushion-like structures located between the bones that make up the spine. These discs serve as shock absorbers and allow for flexibility and movement in the spine. When they break down, they cause back pain, affecting millions of people worldwide. Funded by the European Innovation Council, the VitaDisc project aims to advance current symptomatic treatments and develop a groundbreaking, non-invasive solution that restores disc structure and supports regeneration. This acellular porcine-derived biomatrix is expected to address other unmet orthopaedic needs including early-stage knee joint arthritis.

Objective

Over 400 million people globally suffer from back pain. Disc degeneration disease is the prevalent cause of back pain and it is responsible for high social and economic costs. Current treatments are only symptomatic (physiotherapy, pain management or surgery), but they do not regenerate the disc and its function.
At NC Biomatrix, we have developed VitaDisc, the first non-invasive early restorative treatment for disc degeneration that has the power to revolutionise the orthopaedics market. It is an acellular porcine-derived injectable biomatrix that restores disc height, provides optimal support to regenerate the disc, and aids in restoring healthy spinal biomechanics. Its mode of action is fully mechanical, and it can be easily administered in an outpatient setting, giving it a unique market advantage.
Our biomatrix platform technology is readily scalable and provides a pipeline of further products for unmet needs in orthopaedic treatments, such as early-stage knee joint arthritis.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2022-ACCELERATOR-01

See all projects funded under this call

Coordinator

NC BIOMATRIX BV
Net EU contribution
€ 2 499 999,00
Address
HET EEUWSEL 57
5612AS Eindhoven
Netherlands
SME
Yes
Region
Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 5 222 790,50